(Q39680128)

13 September 2017

title

NADPH oxidase-dependent and -independent mechanisms of reported inhibitors of reactive oxygen generation (English)

1 reference

13 September 2017

Gregory J Gatto

1

1 reference

13 September 2017

Zhaohui Ao

2

1 reference

13 September 2017

Michael G Kearse

3

1 reference

13 September 2017

Mei Zhou

4

1 reference

13 September 2017

Cyndi R Morales

5

1 reference

13 September 2017

Erin Daniels

6

1 reference

13 September 2017

Benjamin T Bradley

7

1 reference

13 September 2017

Matthew T Goserud

8

1 reference

13 September 2017

Krista B Goodman

9

1 reference

13 September 2017

Stephen A Douglas

10

1 reference

13 September 2017

Mark R Harpel

11

1 reference

13 September 2017

Douglas G Johns

12

1 reference

13 September 2017

publication date

3 December 2011

1 reference

Journal of Enzyme Inhibition and Medicinal Chemistry

13 September 2017

published in

1 reference

13 September 2017

volume

28

1 reference

13 September 2017

issue

1

1 reference

13 September 2017

page(s)

95-104

1 reference

Targeting enzyme inhibitors in drug discovery

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2011.636360

The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2011.636360

NADPH oxidases in cardiovascular health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2011.636360

Role of oxidative stress in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2011.636360

Involvement of NADPH oxidases in cardiac remodelling and heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2011.636360

Reactive oxygen species in the cerebral circulation: physiological roles and therapeutic implications for hypertension and stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2011.636360

Nox enzymes, ROS, and chronic disease: an example of antagonistic pleiotropy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2011.636360

Pivotal role of a gp91(phox)-containing NADPH oxidase in angiotensin II-induced cardiac hypertrophy in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2011.636360

Role of p47(phox) in vascular oxidative stress and hypertension caused by angiotensin II.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2011.636360

Deletion of p47phox attenuates angiotensin II-induced abdominal aortic aneurysm formation in apolipoprotein E-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2011.636360

NADPH oxidases, reactive oxygen species, and hypertension: clinical implications and therapeutic possibilities

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2011.636360

The NADPH oxidase of professional phagocytes--prototype of the NOX electron transport chain systems

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2011.636360

Small-molecule NOX inhibitors: ROS-generating NADPH oxidases as therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2011.636360

Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2011.636360

Studies on the inhibitory mechanism of iodonium compounds with special reference to neutrophil NADPH oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2011.636360

A domain of p47phox that interacts with human neutrophil flavocytochrome b558.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2011.636360

Inhibition of NADPH oxidase activation in endothelial cells by ortho-methoxy-substituted catechols

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2011.636360

NADPH oxidases in the vasculature: molecular features, roles in disease and pharmacological inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2011.636360

NADH/NADPH oxidase and enhanced superoxide production in the mineralocorticoid hypertensive rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2011.636360

Novel competitive inhibitor of NAD(P)H oxidase assembly attenuates vascular O(2)(-) and systolic blood pressure in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2011.636360

Gene transfer of NAD(P)H oxidase inhibitor to the vascular adventitia attenuates medial smooth muscle hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2011.636360

NAD(P)H oxidase inhibitor prevents blood pressure elevation and cardiovascular hypertrophy in aldosterone-infused rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2011.636360

Classical inhibitors of NOX NAD(P)H oxidases are not specific.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2011.636360

Effect of the anti-anginal agent, perhexiline, on neutrophil, valvular and vascular superoxide formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2011.636360

Systematic review of the efficacy and safety of perhexiline in the treatment of ischemic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2011.636360

Novel Nox inhibitor VAS2870 attenuates PDGF-dependent smooth muscle cell chemotaxis, but not proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2011.636360

Gene expression in mammalian cells using BacMam, a modified baculovirus system

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2011.636360

Reconstitution of cell-free NADPH oxidase activity by purified components

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2011.636360

Homologs of gp91phox: cloning and tissue expression of Nox3, Nox4, and Nox5

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2011.636360

Mouse model of X-linked chronic granulomatous disease, an inherited defect in phagocyte superoxide production

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2011.636360

Methods for detection of reactive metabolites of oxygen and nitrogen: in vitro and in vivo considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2011.636360

Inhibition of xanthine oxidase by flavonoids

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2011.636360

Roles for beta II-protein kinase C and RACK1 in positive and negative signaling for superoxide anion generation in differentiated HL60 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2011.636360

Impaired NADPH oxidase activity in Rac2-deficient murine neutrophils does not result from defective translocation of p47phox and p67phox and can be rescued by exogenous arachidonic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2011.636360

Structural basis of inhibition of the human NAD+-dependent deacetylase SIRT5 by suramin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2011.636360

Inhibition of carnitine palmitoyltransferase-1 in rat heart and liver by perhexiline and amiodarone

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2011.636360

Comparative pharmacology of chemically distinct NADPH oxidase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F14756366.2011.636360

10.3109/14756366.2011.636360

21 January 2018

Identifiers

DOI

1 reference

13 September 2017

1 reference